Brief: A1M Pharma: Mitochondrial protective effect of rA1M in preclinical studies
Jan 4 (Reuters) - A1M Pharma AB A1M.ST :
* Announces that rA1M shows mitochondrial protective effect,
according to preliminary results from preclinical studies
conducted in cooperation with NeuroVive Pharmaceutical
Source text: http://bit.ly/2iI2Qet
Further company coverage: A1M.ST
(Gdynia Newsroom)
((Gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Disruptive Pharma AB (publ)
See all newsBrief: Disruptive Pharma To Sell GTX Platform To Aurelia Invest AB Unit
Brief: Guard Therapeutics International Q2 Loss Before Tax SEK 4.4 Mln
Brief: Guard Therapeutics Gets Conditional Approval For Continued Listing
Brief: Guard Therapeutics International Initiates Deal Process For Gtx Platform
Brief: Guard Therapeutics Enters Conditional Deal For Reverse Takeover